RESUMO
Background: Short-acting ß2-agonists (SABA) overuse is associated with asthma morbidity and mortality. The SABA use IN Asthma (SABINA) program aimed to describe the global use of SABA in patients with asthma. SABINA III study was a cross-sectional study covering 24 countries. Methods: We performed statistical analysis of the Russian population (618 patients recruited in 12 centers) from the SABINA III study. In this study in patients aged ≥12 years, data on disease characteristics and asthma treatments were collected using real-time electronic case report forms. Patients were classified by asthma severity and control according to the 2017 GINA. All variables (asthma severity and control, number of severe exacerbations, SABA and other medications use) were analyzed descriptively only, no hypothesis was tested. Results: Majority of the study population consisted of patients with moderate/severe asthma (78.5%), while mild asthma was seen in 21.5%. Asthma was uncontrolled in 36.1% of patients and partly controlled in 33.5%. More than 80% of patients were treated with ICS/LABA fixed-dose combination. Almost half of all patients (47.0%) had at least 1 severe exacerbation in the previous 12 months. SABA over-prescription (≥3 canisters per year) was seen in 37% of patients. The frequency of SABA over-prescription was similar in patients with mild (35%) and moderate/severe (38%) asthma. SABA was purchased over-the-counter (OTC) in the past 12 months by 30.1% of all patients, and 14% purchased ≥3 canisters of SABA per year. About 91% of patients who purchased SABA OTC already received prescriptions for SABA, of whom 59% were prescribed ≥3 canisters per year. Conclusion: Russia is seeing very high level of SABA over-prescription. This is potentially associated with poor asthma control and frequent severe exacerbations. Over-prescription may serve as the main cause for SABA overuse in Russia. To reduce SABA overuse and improve overall asthma control in Russia, it is necessary to educate not just the patients but also the doctors, while actively implementing up-to-date asthma treatments.
RESUMO
BACKGROUND: The Volga basin is one of the most industrially-developed regions of Russia with a high degree of anthropogenic impact on natural ecosystems. Human influence negatively affects the species diversity and number of animals, including reptiles. There are no endemic species in the reptile fauna of the Volga basin. The herpetofauna of the region makes up 25% of the reptile fauna of Russia (Dunaev and Orlova 2017). We began to study the fauna of reptiles and their distribution in the Volga basin in 1988. Although we registered 20 reptile species in the Volga basin to date, apparently this is not a complete list of species in the region (Bakiev et al. 2004, Bakiev et al. 2009a, Bakiev et al. 2015, Kirillov et al. 2020). The distribution of reptiles in this region is not fully understood. NEW INFORMATION: Our dataset contains information on reptile occurrences in the Volga River basin. The dataset is based on original research by the staff of the Laboratory of Herpetology and Toxinology and Laboratory of Population Ecology of the Institute of Ecology of the Volga River basin of the Russian Academy of Sciences and Joint Directorate of the Mordovia State Nature Reserve and National Park "Smolny". A total of 5,086 occurrences of 20 species are published for the first time with georeferencing. Many of these reptiles are listed in regional Red Data Lists. The European Pond Turtle Emys orbicularis (Linnaeus, 1758) is included in the IUCN Red List with the category "Near Threatened".
